Ubrig B, Renner K, Fallahi M, Roth S
Klinik für Urologie und Kinderurologie, Univ. Witten/Herdecke, HELIOS-Klinikum Wuppertal.
Aktuelle Urol. 2005 Apr;36(2):136-41. doi: 10.1055/s-2004-830277.
Identification of prognostic factors for tumor recurrence in nephronsparing surgery and tumor progression after organ-preserving surgery.
From June 1989 to February 2003, 43 patients (47 nephron units) underwent organ-preserving surgery or the upper urinary tract because of urothelial carcinoma, with 26 (60.5 %) having an elective indication (healthy contralateral kidney).
The mean follow-up was 39.2 months with a range of 10.6 to 168.3 months. Ipsilateral recurrences occurred in 13 (27.6 %) of reno-ureteral units. Recurrences were significantly more common for tumors located in the renal pelvis or opposite the ureteral origin (p = 0.018). Tumor progression occurred in 8 of 43 patients (18.6 %) and significantly correlated with the T- and G-stage of the primary tumor (p = 0.006 and p = 0.002). Of the 47 conservatively treated reno-ureteral units, 38 (80.8 %) could be preserved.
Organ-preserving resection of the urothelial carcinoma of the upper urinary tract is an alternative in some patients with well-differentiated superficial tumors. A follow-up for life and a good patient compliance are necessary. Tumors of the renal pelvis have a significantly higher recurrence rate than ureteral tumors. Poorly differentiated tumors should undergo organ-preserving surgery only if the goal is palliation and in patients with solitary kidney after intensive consultation about the high risk of invasive recurrences and the development of metastases.
确定保留肾单位手术中肿瘤复发及保器官手术后肿瘤进展的预后因素。
1989年6月至2003年2月,43例患者(47个肾单位)因尿路上皮癌接受了保器官手术或上尿路手术,其中26例(60.5%)有择期手术指征(对侧肾脏健康)。
平均随访39.2个月,范围为10.6至168.3个月。13个(27.6%)肾输尿管单位出现同侧复发。位于肾盂或输尿管起始部相对侧的肿瘤复发明显更常见(p = 0.018)。43例患者中有8例(18.6%)出现肿瘤进展,且与原发肿瘤的T分期和G分期显著相关(p = 0.006和p = 0.002)。在47个接受保守治疗的肾输尿管单位中,38个(80.8%)得以保留。
对于一些高分化浅表性肿瘤患者,上尿路尿路上皮癌的保器官切除术是一种选择。需要终身随访且患者依从性要好。肾盂肿瘤的复发率明显高于输尿管肿瘤。低分化肿瘤仅在以缓解症状为目的且在对侵袭性复发和转移的高风险进行深入咨询后,对于孤立肾患者才应进行保器官手术。